Replies to post #419769 on Amarin Corp Plc (AMRN)

[JRoon71]

Two things:
1. The presentation may have been mostly verbal. The presentation on study design was written (we have seen it posted). But based on what Carol said, it sounds like they were prepping at the last minute just to get preliminary results out at the conference. So it may have just been on an overhead slide with her own explanation.
2. My *hope* is that although it may not have met the endpoints, they were able to achieve some positive results (similar to RESPECT-EPA) - possibly even positive enough to warrant future studies (which was the ultimate goal when they designed the trial originally).